Is iRhythm Technologies, Inc. (IRTC) a Buy, Sell, or Hold?
NASDAQ : IRTC
iRhythm Technologies, Inc.
$107.67 USD
$1.6 (1.51%)
- Volume
- 383.69K
- Average Volume
- 574.19K
- Market Capitalization
- $3.54B
- P/E Ratio
- -125.20
- Dividend Yield
- 0.00%
- Price Target
- $167.50
- Year High
- $212.00
- Year Low
- $100.85
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $5.17
Company Overview
NASDAQ
Quentin S. Blackford
Medical - Devices
Healthcare
IRTC
2400
US
USD
Liquidity Metrics
4.52
5.17
4.98
1.82
0.00
Sales & Valuation
$747.14M
4.49
21.71
188.68
0.58
Profitability
-$1.39
-$44.55M
-3.53%
-3.43%
-20.60%
-2.76%
P/E Metrics
-125.20
-0.88
-0.88
Analyst Price Target & Rating
$167.50
$255.00
$150.00
2/5
20 Analysts
-35.72%
Financial Health Scores
2.80
4/9
$548.81M
$1.01B
$845.16M
-$13.82M
Key Metrics (TTM)
$3.97B
5.05
315.57
5.17
-20.60%
-2.43%
-0.81%
0.54%
62 days
Company Executives
| Name | Title |
|---|---|
| Brian Lawrence | Executive Vice President & Chief Technology Officer |
| Lisa Pecora | Senior Vice President of Finance & Investor Relations |
| Daniel G. Wilson | Chief Financial Officer & Principal Financial Officer |
| Patrick Michael Murphy | Chief Business & Legal Officer |
| Marc Rosenbaum | Senior Vice President of Finance & Chief Accounting Officer |
| Chad Patterson | Chief Commercial and Product Officer |
| Sean Clinton Freeman | Executive Vice President of Strategy & Corporate Development |
| Minang Turakhia | Chief Medical & Scientific Officer and Executive Vice President of Advanced Technologies |
| Mervin Smith | Executive Vice President of Business Operations |
| Quentin S. Blackford | President, Chief Executive Officer & Director |
Poll Results
No votes yet today — be the first to share your view!
About iRhythm Technologies, Inc. (NASDAQ:IRTC) Stock
iRhythm Technologies, Inc. is a digital healthcare enterprise dedicated to offering portable electrocardiogram (ECG) monitoring solutions to individuals in the United States who face the risk of cardiac arrhythmias. Its primary offering, the Zio service, provides a comprehensive ambulatory cardiac monitoring system. This system ingeniously combines a wireless, patch-based, and wearable biosensor—specifically embodied in products like the Zio XT and AT monitors—with a sophisticated cloud-based data analysis platform. These single-use biosensors precisely record a patient's heartbeats and ECG data, thereby enabling medical professionals to effectively oversee patient heart health and accurately diagnose arrhythmias. Furthermore, iRhythm maintains a strategic development partnership with Veri ... ly Life Sciences LLC, focused on pioneering future atrial fibrillation screening, detection, and monitoring innovations. Founded in 2006, the company maintains its corporate headquarters in San Francisco, California.
iRhythm Holdings to Report Second Quarter 2026 Financial Results on August 6, 2026
2026-07-16 16:05:00
SAN FRANCISCO, July 16, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced that it will release financial results for the second quarter 2026 after the close of trading on Thursday, August 6, 2026. The company's management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET.
Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
2026-07-03 12:38:00
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm
2026-07-02 17:28:00
NEW YORK, July 2, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of iRhythm Technologies, Inc. (NASDAQ: IRTC) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at iRhythm caused the company to misrepresent or fail to disclose that the Zio AT monitor was a real-time monitor intended for high-risk patients.
Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm
2026-06-30 16:48:00
NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of iRhythm Technologies, Inc. (NASDAQ: IRTC) breached their fiduciary duties to shareholders.
iRhythm discloses cyber incident, says no impact on device systems, patient safety
2026-06-15 18:45:09
iRhythm Holdings on Monday reported unauthorized activity involving data maintained on some third-party applications last week, but said it has not identified any impact on products, patient safety or medical device systems from the cyber attack.
iRhythm Holdings to Participate in Upcoming Investor Conferences
2026-05-19 16:05:00
SAN FRANCISCO, May 19, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that the company will be participating in the following investor conferences.
iRhythm Technologies Touts Medicare Win, Zio Growth and AI-Driven Margin Gains
2026-05-18 07:04:56
iRhythm Technologies NASDAQ: IRTC executives said the company is seeing continued business momentum after a favorable Medicare coverage update, a stronger-than-expected first quarter and progress on several product and margin initiatives.
2026-05-13 15:00:44
iRhythm Holdings, Inc. (IRTC) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Frequently Asked Questions
-
What is the current iRhythm Technologies, Inc. (IRTC) stock price?
-
iRhythm Technologies, Inc.(NASDAQ:IRTC) stock price is $107.67 in the last trading session. During the trading session, IRTC stock reached the peak price of $212 while $100.846 was the lowest point it dropped to. The percentage change in IRTC stock occurred in the recent session was 1.51% while the dollar amount for the price change in IRTC stock was $1.6.
-
IRTC's industry and sector of operation?
-
The NASDAQ listed IRTC is part of Medical - Devices industry that operates in the broader Healthcare sector.
-
Who are the executives of IRTC?
-
Brian Lawrence | Executive Vice President & Chief Technology Officer
Lisa Pecora | Senior Vice President of Finance & Investor Relations
Daniel G. Wilson | Chief Financial Officer & Principal Financial Officer
Patrick Michael Murphy | Chief Business & Legal Officer
Marc Rosenbaum | Senior Vice President of Finance & Chief Accounting Officer -
How many employees does IRTC have?
-
Number of IRTC employees currently stands at 2400. IRTC operates from 699 8th Street, San Francisco, CA 94103, US.
-
Link for IRTC official website?
-
Official Website of IRTC is: https://www.irhythmtech.com
-
How do I contact IRTC?
-
IRTC could be contacted at phone #415 632 5700 and can also be accessed through its website. IRTC operates from 699 8th Street, San Francisco, CA 94103, US.
-
How many shares of IRTC are traded daily?
-
The average number of IRTC shares traded daily for last 3 months was 574.19K.
-
What is the market cap of IRTC currently?
-
The market value of IRTC currently stands at $3.54B with its latest stock price at $107.67